Enovis vs Zimmer Biomet: revenue, profit, margins and growth compared
Enovis brought in $2.2B of revenue in fiscal 2025, Zimmer Biomet $8.2B in fiscal 2025. Revenue changed by +6.7% at Enovis and +7.2% at Zimmer Biomet on the year before, so Zimmer Biomet grew faster. Enovis kept -52.7% of its revenue as net profit, Zimmer Biomet 8.6%. Free cash flow was $19.9M at Enovis and $1.5B at Zimmer Biomet.
Fiscal years as each company reports them; the two may end in different months.
Questions about Enovis and Zimmer Biomet
Which is bigger by revenue, Enovis or Zimmer Biomet?
Zimmer Biomet is bigger by revenue: $8.2B in fiscal 2025, against $2.2B for Enovis in fiscal 2025.
Which keeps more of its revenue as profit, Enovis or Zimmer Biomet?
Enovis had a net margin of -52.7% in fiscal 2025; Zimmer Biomet had 8.6% in fiscal 2025.
Which grew revenue faster, Enovis or Zimmer Biomet?
In their latest fiscal years revenue changed by +6.7% at Enovis and +7.2% at Zimmer Biomet.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.